Navigation Links
Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
Date:12/14/2008

rence is 'low' or 'high'," said Dr. Sgroi. "The ability to reduce the number of patients in the 'intermediate' group by reclassifying them as either 'high' or 'low' risk, making risk prediction more specific, should go a long way in helping medical professionals select the most appropriate therapy for each of their patients."

On Saturday, Matthew Goetz, M.D., from Mayo Clinic and colleagues from Austria presented data examining the predictive utility of CYP2D6 and the prognostic utility of the Theros Breast Cancer Index in women with breast cancer randomized to receive five years of treatment with tamoxifen or two years of tamoxifen followed by three years anastrozole treatment. The researchers found that the Theros Breast Cancer Index will identify, among patients with early stage breast cancer, those with a higher risk of treatment failure when treated only with hormonal therapy. They concluded that the Theros Breast Cancer Index identified approximately 25 percent of grade 1 and grade 2 breast cancers that had a nearly three-fold higher risk for a subsequent recurrence in distant organs.

Finally, data from a study presented on Sunday by Olle Stal, PhD, and colleagues from Linkoping University in Sweden explored the value of the HOXB13 gene in predicting benefit of tamoxifen therapy. Researchers reviewed HOXB13 protein expression in tumor samples from 866 patients with estrogen- receptor positive tumors. Patients whose tumors expressed no or low levels of HOXB13 had a clear benefit from tamoxifen in terms of longer distant recurrence-free survival. Patients with a high or intermediate HOXB13 expression did not experience a distant recurrence-free survival benefit from tamoxifen as compared to untreated patients.

"Data from these studies reinforce clinical and research experience to date which has shown that the Theros Breast Cancer Index is an excellent test for assessing breast cancer risk prognosi
'/>"/>

SOURCE bioTheranostics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
3. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
4. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
5. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
6. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
7. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
8. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014   Mast Therapeutics, ... company, announced today that Santosh Vetticaden, Chief Medical ... the Company, for personal reasons, in mid-September.  ... Officer of Aires Pharmaceuticals, which Mast acquired earlier ... as the Company,s interim Chief Medical Officer.  Dr. ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Peptide Cancer Therapeutics Market & Pipeline ... The conventional methods developed to prevent and eradicate ... cancer treatment. These methods are confined to low specificity, ... the researchers to look for a better solution. It ...
(Date:8/29/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... District of New Jersey has ... Sandoz, Inc. regarding United Therapeutics, Remodulin ® product.  In ... U.S. Patent No. 6,765,117 is both valid and enforceable ... generic product until the expiration of that patent in ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2
... RIDGEFIELD, CT, Sept. 21, 2011 Boehringer Ingelheim,s investigational ... trend in reducing lung function decline in patients with ... trial results published today online in the New ... is a progressive and severely debilitating lung disease with ...
... new electronic medication system, the Artemis system, is now in ... which adds a new level of safety when it ... an emergency situation. The Artemis system ...  Dr. James Broselow, inventor of ,The Broselow Tape, and Dr. ...
Cached Medicine Technology:New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis 2New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis 3New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis 4New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis 5New Electronic Child Medication Safety System Launches at Rocky Mountain Hospital for Children at Presbyterian/St. Luke's Medical Center 2New Electronic Child Medication Safety System Launches at Rocky Mountain Hospital for Children at Presbyterian/St. Luke's Medical Center 3
(Date:9/1/2014)... September 02, 2014 PAINWeek, the National ... the American Pain Society (APS) will return to the ... expertise in pain management to the agenda. This activity ... no fee to attend this program. , On Thursday, ... activity that complies with the FDA’s Risk Evaluation and ...
(Date:9/1/2014)... State University study of deadly force were more likely ... when it came time to shoot, participants were biased ... the trigger against them than against armed white or ... Journal of Experimental Criminology , grow out of dozens ... ethnic and racial minorities shot by police. The studies ...
(Date:9/1/2014)... iFitDress.com, a professional company of women’s dresses and ... modest evening dresses . In addition, the company ... evening gowns. All customers can enjoy a big discount, ... , iFitDress.com is one of the leading suppliers in ... are striving to create more trendy items. The company's ...
(Date:9/1/2014)... AZ (PRWEB) September 01, 2014 Building ... conference, the American Sleep and Breathing Academy ... conference: A Conference for Healthcare Professionals. The event will ... Arizona on April 10th and 11th. This years’ event ... delivered by the ASBA. , In recent years, ...
(Date:9/1/2014)... was associated with mental health and substance use ... protect teens from the consequences of cyberbullying and ... Author: Frank J. Elgar, Ph.D., of McGill University, ... in 5 adolescents has experienced recent online bullying ... risk of mental health problems in teens as ...
Breaking Medicine News(10 mins):Health News:American Pain Society Returns with REMS Training at PAINWeek 2014 in Las Vegas 2Health News:WSU 'deadly force' lab finds racial disparities in shootings 2Health News:WSU 'deadly force' lab finds racial disparities in shootings 3Health News:iFitDress.com: New Modest Evening Wear Selection Now Unveiled Online 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 3Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 4Health News:Family dinners good for teens' mental health, could protect from cyberbullying 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 3
... Twelve senior U.S. editors and producers traveled to ... of Africa,s most fascinating countries. A highlight of the ... development, food security, and HIV/AIDS with Ugandan President Yoweri ... at noon , three of the Gatekeepers will discuss ...
... number of childhood deaths across the country have been linked ... this serious and sometimes deadly disease with an annual flu ... a relatively high level across the country, now is the ... do so. It takes about two weeks for the body ...
... Sleep Awareness Week -- March 1-8 -- ... importance of a good night,s sleep by raising ... sleep bruxism. (Logo: http://www.newscom.com/cgi-bin/prnh/20070809/AQTH133LOGO )Sleep bruxism is ... associated with sleep deprivation, stress or misalignment of ...
... showing at the 2009,South Beach Food and Wine Festival, ... 300 stores in South Florida since the brand launched ... include: CVS on Lincoln Road,Miami Beach; Walgreens, Miami Beach; ... Thumb, Penn Dutch, Quick Stop, Shell Gas Stations, and,Chevron. ...
... in Health Incentive ProgramsLYNDHURST, N.J., Feb. 24 ... to the health care industry, announced today that ... serve the industry in the area of incentive ... seasoned health and productivity professionals have long been ...
... to help health care providers,prepare patients for a colonoscopy ... makes TriLyte(R) (PEG-3350, sodium chloride, sodium bicarbonate,and potassium chloride ... is indicated for bowel cleansing prior to a,colonoscopy. , ... patients who are preparing for a,colonoscopy by explaining the ...
Cached Medicine News:Health News:U.S. Media Report From Uganda: Wilson Center Panel Discusses Health, Environment, and Security in Africa 2Health News:Recently Reported Childhood Deaths from Influenza Are a Stark Reminder to Vaccinate Now 2Health News:GIVE IT A REST: Delta Dental of Illinois Encourages Routine Dental Exams to Help Detect Nighttime Teeth Grinding 2Health News:Next Generation Waters Successfully Reaches Over 300 Stores! 2Health News:IncentOne Launches Consulting Practice 2Health News:Free Video for Health Care Providers and Patients Who are Preparing for a Colonoscopy Is Now Available at www.TriLyte.com 2
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size....
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end....
Double-ended. Semi sharp. Curved 3 mm tips. Angled right and left....
Double-ended. Designated most popular model or size....
Medicine Products: